A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.

Condition:   Prostate CancerIntervention:   Drug: Triptorelin 11.25 mgSponsor:   IpsenRecruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials